Gut microbiota and cardiovascular risk factors. Part IV. Arterial hypertension, smoking and the gut microbiota
https://doi.org/10.15829/1728-8800-2016-1-69-72
Abstract
The collected data on the interaction of human-as-host and their gut microbiota reveals new opportunities for further investigation and translation to practice the novel methods of the body influence in whole and on separate systems, particularly via correction of gut microbiota condition. Previous reviews focused on recent data on the interaction of gut microbiota with the main cariovascular risk factors. Last article in this sequel focuses on the recent data on hypertension and condition of the gut microbiota, as on the influence of smoking on the gut microbiota.
The article presents the results of investigations on the influence of short-chain fatty acids on arterial pressure, and on smoking impact on the gut microbiota.
About the Authors
D. A. Kashtanova
National Research Center for Preventive Medicine of the Ministry of Health. Moscow, Russia
Russian Federation
Russian Federation
O. N. Tkacheva
National Research Center for Preventive Medicine of the Ministry of Health. Moscow, Russia
Russian Federation
Russian Federation
S. A. Boytsov
National Research Center for Preventive Medicine of the Ministry of Health. Moscow, Russia
Russian Federation
Russian Federation
References
1. Gelfer M, Drouin D, Dawes M, et al. World Health Day: focusing on hypertension in 2013. Can Fam Physician 2013; 59(4): 341-2.
2. World Health Organization. WHO global report on mortality attributable to tobacco. 2012, Geneva: World Health Organization. 392 p.
3. Chen Y, Liu W, Xue J, et al., Angiotensin-converting enzyme inhibitory activity of Lactobacillus helveticus strains from traditional fermented dairy foods and antihypertensive effect of fermented milk of strain H9. J Dairy Sci 2014; 97(11): 6680-92.
4. Qian B, Xing M, Cui L, et al. Antioxidant, antihypertensive, and immunomodulatory activities of peptide fractions from fermented skim milk with Lactobacillus delbrueckii ssp. bulgaricus LB340. J Dairy Res 2011; 78(1): 72-9.
5. Jauhiainen T, Vapaatalo H, Poussa T, et al. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 2005; 18(12 Pt 1): 1600-5.
6. Jauhiainen T, Korpela R, Roennback M, et al. New use of therapeutically useful peptides. 2007, Patents WO2007132054 A1.
7. Cho YR, Chang JY, Chang HC. Production of gamma-aminobutyric acid (GABA) by Lactobacillus buchneri isolated from kimchi and its neuroprotective effect on neuronal cells. J Microbiol Biotechnol 2007; 17(1): 104-9.
8. Mazzoli R, Pessione E, Dufour M, et al. Glutamate-induced metabolic changes in Lactococcus lactis NCDO 2118 during GABA production: combined transcriptomic and proteomic analysis. Amino Acids 2010; 39(3): 727-37.
9. Inoue K, Shirai T, Ochiai H, et al. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 2003; 57(3): 490-5.
10. Penas E, Diana M, Frias J, et al. A multistrategic approach in the development of sourdough bread targeted towards blood pressure reduction. Plant Foods Hum Nutr 2015; 70(1): 97-103.
11. Ringel-Kulka T, Goldsmith JR, Carroll IM, et al. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study. Aliment Pharmacol Ther 2014; 40(2): 200-7.
12. Rousseaux C, Thuru X, Gelot A, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13(1): 35-7.
13. Ebner J, Asci Arslan A, Fedorova M, et al. Peptide profiling of bovine kefir reveals 236 unique peptides released from caseins during its production by starter culture or kefir grains. J Proteomics 2015; 117: 41-57.
14. Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A 2013; 110(11): 4410-5.
15. Pluznick J. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes 2014; 5(2): 202-7.
16. Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res 2012; 91(2): 142-9.
17. Wang H, Zhao JX, Hu N, et al. Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins. World J Gastroenterol 2012; 18(18): 2180-7.
18. Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One 2013; 8(3): e59260.
19. Parkes GC, Whelan K, Lindsay JO. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 2014; 8(8): 717-25.
20. Derkinderen P, Shannon K.M, Brundin P. Gut feelings about smoking and coffee in Parkinson's disease. Mov Disord 2014; 29(8): 976-9.
Review
For citations:
Kashtanova D.A., Tkacheva O.N., Boytsov S.A. Gut microbiota and cardiovascular risk factors. Part IV. Arterial hypertension, smoking and the gut microbiota. Cardiovascular Therapy and Prevention. 2016;15(1):69-72. (In Russ.) https://doi.org/10.15829/1728-8800-2016-1-69-72
Views:
2429
Email this article 
